1. Home
  2. DERM vs BGX Comparison

DERM vs BGX Comparison

Compare DERM & BGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DERM

Journey Medical Corporation

HOLD

Current Price

$6.40

Market Cap

135.3M

Sector

Health Care

ML Signal

HOLD

Logo Blackstone Long Short Credit Income Fund

BGX

Blackstone Long Short Credit Income Fund

HOLD

Current Price

$10.92

Market Cap

135.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DERM
BGX
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
135.3M
135.2M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
DERM
BGX
Price
$6.40
$10.92
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$12.67
N/A
AVG Volume (30 Days)
256.8K
58.7K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
34.72
N/A
EPS
N/A
N/A
Revenue
$61,858,000.00
N/A
Revenue This Year
$39.72
N/A
Revenue Next Year
$63.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.20
N/A
52 Week Low
$4.31
$10.38
52 Week High
$9.56
$12.65

Technical Indicators

Market Signals
Indicator
DERM
BGX
Relative Strength Index (RSI) 64.73 53.24
Support Level $4.84 $10.76
Resistance Level $6.71 $10.97
Average True Range (ATR) 0.40 0.07
MACD 0.08 0.00
Stochastic Oscillator 85.90 83.67

Price Performance

Historical Comparison
DERM
BGX

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About BGX Blackstone Long Short Credit Income Fund

Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. The company's seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.

Share on Social Networks: